BASILEA Trademark

Trademark Overview


On Thursday, March 10, 2016, a trademark application was filed for BASILEA with the United States Patent and Trademark Office. The USPTO has given the BASILEA trademark a serial number of 86936140. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 4, 2019. This trademark is owned by Basilea Pharmaceutica AG. The BASILEA trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area ...

Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
basilea

General Information


Serial Number86936140
Word MarkBASILEA
Filing DateThursday, March 10, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 4, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 9, 2016

Trademark Statements


Indication of Colors claimedThe color(s) blue and white is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "BASILEA" in blue surrounded by an oval in blue, with the interior of the oval in white.
Goods and ServicesChemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
Goods and ServicesPharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only
Goods and ServicesResearch and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, March 15, 2016
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 15, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBasilea Pharmaceutica AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4058
CH

Party NameBasilea Pharmaceutica AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address4058 Basel
CH

Trademark Events


Event DateEvent Description
Monday, November 4, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 4, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 18, 2019CORRECTED NOA E-MAILED
Thursday, May 16, 2019DIVISIONAL PROCESSING COMPLETE
Monday, May 6, 2019DIVISIONAL REQUEST RECEIVED
Monday, May 6, 2019TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, March 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2019EXTENSION 5 GRANTED
Wednesday, February 27, 2019EXTENSION 5 FILED
Tuesday, March 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 27, 2019TEAS EXTENSION RECEIVED
Friday, September 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 19, 2018EXTENSION 4 GRANTED
Wednesday, September 19, 2018EXTENSION 4 FILED
Wednesday, September 19, 2018TEAS EXTENSION RECEIVED
Wednesday, March 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 19, 2018EXTENSION 3 GRANTED
Monday, March 19, 2018EXTENSION 3 FILED
Monday, March 19, 2018TEAS EXTENSION RECEIVED
Tuesday, September 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 23, 2017EXTENSION 2 GRANTED
Saturday, September 23, 2017EXTENSION 2 FILED
Saturday, September 23, 2017TEAS EXTENSION RECEIVED
Wednesday, March 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2017EXTENSION 1 GRANTED
Monday, March 27, 2017EXTENSION 1 FILED
Monday, March 27, 2017TEAS EXTENSION RECEIVED
Tuesday, October 4, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 22, 2016ASSIGNED TO EXAMINER
Wednesday, March 16, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, March 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 14, 2016NEW APPLICATION ENTERED IN TRAM